LOS ANGELES, Jan. 12 /PRNewswire/ -- The Prostate Cancer Foundation today announced the recipients of the Foundation’s 2003 Competitive Research Awards. This venture-style research funding mechanism provides support to high impact research projects with the highest likelihood of providing improved near-term treatments for men with recurrent prostate cancer.
The awards are made in a variety of research areas, including genomics, molecular biology, angiogenesis, signal transduction, experimental models, apoptosis, new drug discovery, nutrition, alternative therapies, and clinical medicine. Since the program was established in 1993, emphasis has shifted from basic science to specific treatment applications. The 2003 awards focus on projects with direct clinical treatment application or where results would soon lead to a treatment-enabling outcome.
Dr. Howard R. Soule, Chief Science Officer of the Prostate Cancer Foundation, commented, “The Competitive Awards constitute the largest part of the Foundation’s programs to accelerate the search for better treatments and a cure for recurrent prostate cancer. This year, we granted Competitive Awards totaling $3.375 million to 37 scientists and physicians. The Prostate Cancer Foundation is the largest, non-profit supporter of breakthrough science in prostate cancer. We are proud of our role in this area and the continued generosity of our donors who support these efforts.”
The Prostate Cancer Foundation’s 2003 Competitive Award recipients are: David Agus, M.D. - Cedars-Sinai, Prostate Cancer Center David Berman, MD., Ph.D. - The Johns Hopkins University Michael Carducci, M.D. - The Johns Hopkins University June Chan, Sc.D. - University of California, San Francisco Gerhard Coetzee, Ph.D. - University of Southern California Colin Collins, Ph.D. - University of California, San Francisco Marc Diamond, M.D. - University of California, San Francisco Phillip Febbo, M.D. - Dana-Farber Cancer Institute Robert Fletterick, Ph.D. - University of California, San Francisco Martin Gleave, M.D. - Vancouver General Hospital Theresa Guise, M.D. - University of Virginia Rodney Guy, Ph.D. - University of California, San Francisco Susan Halabi, Ph.D. - Duke University Medical Center John Isaacs, Ph.D. - Johns Hopkins University David Jarrard, M.D. - University of Wisconsin Richard Junghans, M.D., Ph.D. - Beth Israel Deaconess Medical Center Philip Kantoff, M.D. - Dana-Farber Cancer Institute Andrew Kraft, M.D. - University of Colorado Sue-Hwa Lin, Ph.D. - M.D. Anderson Cancer Center Massimo Loda, M.D. - Dana-Farber Cancer Institute Jeffrey Milbrandt, M.D., Ph.D. - Washington University Peter Nelson, M.D. - Fred Hutchinson Cancer Research Center William Nelson, M.D., Ph.D. - Johns Hopkins University Kenneth Pienta, M.D. - University of Michigan John Reed, M.D., Ph.D. - Burnham Institute Neal Rosen, M.D., Ph.D. - Memorial Sloan-Kettering Cancer Center Michael Rosenfeld, M.D., Ph.D. - University of California, San Diego Charles Sawyers, M.D. - University of California, Los Angeles Howard Scher, M.D. - Memorial Sloan-Kettering Cancer Center William Sellers, M.D. - Dana-Farber Cancer Institute David Solit, M.D. - Memorial Sloan-Kettering Cancer Center Terry Van Dyke, Ph.D. - University of North Carolina at Chapel Hill Bingcheng Wang, Ph.D. - Case Western Reserve University Shaomeng Wang, Ph.D. - University of Michigan George Wilding, M.D. - University of Wisconsin Owen Witte, M.D. - University of California, Los Angeles Hong Wu, M.D., Ph.D. - University of California, Los Angeles
Further information on each of the awarded programs can be found at http://www.prostatecancerfoundation.org/.
About the Prostate Cancer Foundation
The Prostate Cancer Foundation is dedicated to finding better treatments and a cure for recurrent prostate cancer. Since inception in 1993, the Prostate Cancer Foundation (PCF) has become the world’s largest philanthropic source of support for prostate cancer research. The PCF has raised approximately $200 million and funded more than 1,100 critical research projects in 100 research centers around the world. The PCF invests 78 cents of every dollar raised on medical and scientific research; more than three times the average amount spent by the other major health-care philanthropies. Further information is available at http://www.prostatecancerfoundation.org/ .
CONTACT: Erika Beck, the Prostate Cancer Foundation, +310-570-4705, or Justin Jackson, Burns McClellan for the Prostate Cancer Foundation, +1-212-213-0006
The Prostate Cancer Foundation
CONTACT: Erika Beck, the Prostate Cancer Foundation, +1-310-570-4705;Justin Jackson of Burns McClellan for the Prostate Cancer Foundation,+1-212-213-0006, for The Prostate Cancer Foundation
Web Site: http://www.prostatecancerfoundation.org/